Sabby Management, LLC Daxor Corp Transaction History

Sabby Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$10.51 - $11.52 $220,667 - $241,873	-20,996 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$10.59 - $11.5 $391,067 - $424,672	-36,928 Reduced 63.75%	20,996 $237,000
Q3 2021 Nov 15, 2021	SELL	$8.77 - $12.05 $346,967 - $476,734	-39,563 Reduced 40.58%	57,924 $677,000
Q2 2021 Aug 16, 2021	SELL	$8.9 - $14.15 $189,116 - $300,673	-21,249 Reduced 17.9%	97,487 $1.03 Million
Q1 2021 May 17, 2021	SELL	$11.02 - $13.86 $106,475 - $133,915	-9,662 Reduced 7.53%	118,736 $1.44 Million
Q4 2020 Feb 16, 2021	BUY	$12.15 - $15.77 $72,802 - $94,493	5,992 Added 4.9%	128,398 $1.61 Million
Q3 2020 Nov 16, 2020	BUY	$14.66 - $23.78 $1.79 Million - $2.91 Million	122,406 New	122,406 $1.93 Million

79.4K

Ticker DXR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 4,041,670
Market Cap $35.9M
Description
Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used i...

Get notified when there are updates to the investment portfolio of Sabby Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sabby Management, LLC with notifications on news.